I think 2017 will be a stellar year for biotech in the wake of an election in which the forces calling for immediate drug price reform were soundly defeated. Additionally the new administration plans to allow BP to repatriate billions of overeseas dollars which undoubtedly will facilitate a new round of M and A activity, probably the most ever for BP's desperately needing new products. We haven't seen a resurgence in the sector like we have seen recently in over a year. The institutions are jumping onboard for good reason. They know it will be many months or even years before any consequential legislation gets passed which will hurt Biotech and Ariad specifically. That's plenty of time to get Brigatinib approved and the company sold probably in the high 20's (or higher if the sp is already in the 20's which it certainly may be by the Brigatinib approval). Those saying differently also said Ariad would suffer in a lose-lose scenario no matter who won... well look how that prediction turned out! This person said the market would take a huge hit if Trump won but hiw completely wrong was that prediction! Same thing as the bad call about the company being sold for 15 in October. Again, completely wrong! This is a golden period for Ariad and biotech. Taking profits now is fine but I sure would not sell the whole position. I am thrilled with selling a few shares at 14 and feel great about not selling any at 2 like some did. But most assuredly this stock is going much higher and very likely quite soon. To predict the demise of the most robust industry in America is sheer fantasy. Trump admires entrepreneurship and isnt going to stop the advance of research for new medicines no matter how much some say otherwise. Sure someday there will be a diluted lame effort to promote "drug pricing reform" but that will be aimed at the older generics being reined in, not the new, often orphan drugs which cost billions to develop. Trump of all people understands the cost of doing business. Denner saved the company at 2, got it to 14, and now the Trump administration will facilitate a sale in the high 20's or 30's. Just sayin.
